SCHEMBL4084344

SCHEMBL4084344

CC(C)CC(N)C(C)(C)N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPK1 P28482 1/20 0.45
ANPEP P15144 6/20 0.38
ERAP1 Q9NZ08 2/20 0.38
ERAP2 Q6P179 1/20 0.38
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
NFKB1 P19838 1/20 0.36
THPO P40225 1/20 0.36
GMNN O75496 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
PMP22 Q01453 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SLC7A5 Q01650 1/20 0.35
LAP3 P28838 3/20 0.33
SLC1A3 P43003 1/20 0.30
SLC1A2 P43004 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7057709 0.79 TSHR (0.47) TSHRALDH1A1MAPK1ANPEPERAP1
SCHEMBL17452221 0.79 TSHR (0.47) TSHRALDH1A1MAPK1ANPEPERAP1
SCHEMBL14569561 0.79 TSHR (0.47) TSHRALDH1A1MAPK1ANPEPERAP1
SCHEMBL12816393 0.76 TSHR (0.39) TSHRALDH1A1MAPK1ANPEPERAP1
SCHEMBL89791 0.74 TSHR (0.43) TSHRALDH1A1MAPK1ANPEPERAP1
SCHEMBL1153769 0.74 TSHR (0.43) TSHRALDH1A1MAPK1ANPEPERAP1
SCHEMBL89773 0.74 TSHR (0.43) TSHRALDH1A1MAPK1ANPEPERAP1
SCHEMBL11422093 0.74 TSHR (0.38) TSHRALDH1A1MAPK1ANPEPERAP1
SCHEMBL8369038 0.73 TSHR (0.40) TSHRALDH1A1MAPK1ANPEPERAP1
Hydrochloric Acid SCHEMBL22749249 0.72 TSHR (0.41) TSHRALDH1A1MAPK1ANPEPERAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2009518522-A 2009-05-07 JP claimed
EP-1966311-A2 VISCOSITY-REDUCED SPRAYABLE COMPOSITIONS Tyco Healthcare Group, LP (US) 2008-09-10 EP claimed
JP-2008517094-A 2008-05-22 JP claimed
EP-1812492-A1 HIGH-TEMPERATURE RIGID POLYURETHANE SPRAY FOAM FOR PIPE INSULATION Bayer MaterialScience LLC (US) 2007-08-01 EP claimed
WO-2007067761-A2 VISCOSITY-REDUCED SPRAYABLE COMPOSITIONS TYCO HEALTHCARE GROUP LP (US) 2007-06-14 WO claimed
WO-2006044365-A1 HIGH-TEMPERATURE RIGID POLYURETHANE SPRAY FOAM FOR PIPE INSULATION BAYER MATERIALSCIENCE LLC (US) 2006-04-27 WO claimed
EP-1159261-B1 ANTIZYME MODULATORS AND THEIR USE ORIDIGM CORP (US) 2005-11-02 EP claimed
EP-1159261-A2 ANTIZYME MODULATORS AND THEIR USE ORIDIGM CORPORATION (US) 2001-12-05 EP claimed
WO-2000046187-A2 ANTIZYME MODULATORS AND THEIR USE ORIDIGM CORPORATION (US) 2000-08-10 WO claimed
US-11925925-B2 Ionic polymers and use thereof in biomass processing EMBION TECHNOLOGIES SA (CH) 2024-03-12 US disclosed
CN-111356711-B Ionic polymers and their use in biomass processing 埃姆比昂技术公司 2022-06-10 CN disclosed
US-20200246785-A1 IONIC POLYMERS AND USE THEREOF IN BIOMASS PROCESSING EMBION TECHNOLOGIES SA (CH) 2020-08-06 US disclosed
CN-111356711-A Ionic polymers and their use in biomass processing 埃姆比昂技术公司 2020-06-30 CN disclosed
EP-3084339-B1 BALLISTIC-RESISTANT STRUCTURAL INSULATED PANELS COVESTRO LLC (US) 2019-04-17 EP disclosed
EP-1159261-B1 ANTIZYME MODULATORS AND THEIR USE ORIDIGM CORP (US) 2005-11-02 EP disclosed
US-20050222289-A1 Process and apparatus for producing rigid polyurethane foam BAYER MATERIALSCIENCE LLC 2005-10-06 US disclosed
EP-1159261-A2 ANTIZYME MODULATORS AND THEIR USE ORIDIGM CORPORATION (US) 2001-12-05 EP disclosed
WO-2000046187-A2 ANTIZYME MODULATORS AND THEIR USE ORIDIGM CORPORATION (US) 2000-08-10 WO disclosed
US-5889066-A POLYURETHANE BAYER CORPORATION (US) 1999-03-30 US disclosed
US-5840212-A BLOWING AGENTS BAYER CORPORATION (US) 1998-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11925925-B2 Ionic polymers and use thereof in biomass processing IPMK, INPP5A, MPI TSHR 4751/4885ALDH1A1 4577/4885MAPK1 3276/4885
US-20200246785-A1 IONIC POLYMERS AND USE THEREOF IN BIOMASS PROCESSING IPMK, INPP5A, MPI TSHR 4751/4885ALDH1A1 4577/4885MAPK1 3276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.